PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Phenotype | |hepatocellular carcinoma |
| Sentences | 124 |
| PubMedID- 21133598 | Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 25559682 | The aim of the present study was to evaluate wfa(+) -m2bp as a predictor of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 24081938 | Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted. |
| PubMedID- 21253791 | Overall, these data suggest that chemoprevention of hepatocellular carcinoma in patients with chronic hepatitis c is an achievable objective. |
| PubMedID- 21286221 | A 72-year-old japanese man underwent partial resection of the liver for hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 21331763 | Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21963516 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2890 hcv-negative controls of japanese origin. |
| PubMedID- 22066022 | Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma. |
| PubMedID- 24462733 | A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis. |
| PubMedID- 22875473 | Inhibition of hepatocellular carcinoma by pegifnalpha-2a in patients with chronic hepatitis c: a nationwide multicenter cooperative study. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 23395693 | Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis c: further evidence in decompensation cirrhosis. |
| PubMedID- 26469163 | Methods: thirty consecutive cases of percutaneous arterial chemoembolization for hepatocellular carcinoma with hepatitis c-related cirrhosis(male, 23; female, 7; age, 74+/-5.9; weight, 62.7+/-12.3 kg; child-pugh a, 23; child-pugh b, 7)were analyzed retrospectively. |
| PubMedID- 23860735 | Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 26424404 | Background: end-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) co-infection are increasingly common causes of death among hiv-infected individuals. |
| PubMedID- 19935643 | Chronic hepatitis c viral infection can lead to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 24752298 | Chronic hepatitis c (chc) can lead to cirrhosis and hepatocellular carcinoma (lauer and walker, 2001). |
| PubMedID- 24367218 | Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus. |
| PubMedID- 19879972 | Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related cirrhosis. |
| PubMedID- 21931376 | Objectives: prospective studies of serum hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c are lacking. |
| PubMedID- 21157144 | A 57-yr-old female patient with hepatocellular carcinoma due to hepatitis c virus received a liver transplantation. |
| PubMedID- 23547582 | Screening for hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 24703510 | Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection. |
| PubMedID- 22695885 | Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis. |
| PubMedID- 23689989 | Il28b minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis c virus infection. |
| PubMedID- 20404016 | The incidence of hepatocellular carcinoma is rising due to alcohol drinking, hepatitis c viral infection and metabolic syndrome. |
| PubMedID- 23982634 | Effect of occult hepatitis b virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 25788045 | Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment. |
| PubMedID- 22879825 | hepatocellular carcinoma complicates 5% of the chronic hepatitis c cases [1][2]. |
| PubMedID- 26394142 | End-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) infection constitute one of the main indications for liver transplantation (lt) worldwide [1]. |
| PubMedID- 22957141 | End-stage liver diseases as well as hepatocellular carcinoma attributable to chronic hepatitis c are increasingly serious problems2. |
| PubMedID- 24179611 | Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis. |
| PubMedID- 24223741 | Purpose: recent studies have revealed that branched-chain amino acids (bcaa) reduce the development of hepatocellular carcinoma (hcc) in patients with obesity and hepatitis c virus infection by improving insulin resistance (ir). |
| PubMedID- 22414050 | Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis c-related cirrhosis: a meta-analysis of randomized controlled trials. |
| PubMedID- 24843320 | Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 25331666 | [increased risk of hepatocellular carcinoma in patients with chronic hepatitis c.] |
| PubMedID- 24409059 | Aim: to study the potential association between hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc), cirrhosis and latent hepatitis b (lhb) infection, defined as the absence of detectable serum hepatitis b surface antigen (hbsag) and the presence of hepatitis b core antibody (hbcab). |
| PubMedID- 23099187 | Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study. |
| PubMedID- 20883676 | Background: there are few blood tests for an efficient detection of hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection. |
| PubMedID- 22419005 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 22212964 | Viral hepatitis among somali immigrants in minnesota: association of hepatitis c with hepatocellular carcinoma. |
| PubMedID- 22743730 | Case report: a 60 year-old man underwent ldlt for hepatitis c virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 23463401 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region. |
| PubMedID- 23602201 | High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 22013259 | The first patient was a 45-year-old male hepatitis c related cirrhosis with hepatocellular carcinoma, child grade c, with refractory ascites, coagulopathy and mild hepatorenal syndrome. |
| PubMedID- 25912838 | We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis. |
| PubMedID- 26191473 | In addition, dm has been suggested to enhance the development of hepatocellular carcinoma in patients with chronic hepatitis c (kawamura et al. |
| PubMedID- 24393884 | Case 1 involved a 63-year-old woman who had multiple hepatocellular carcinomas (hcc) associated with hepatitis c virus infection. |
| PubMedID- 26017875 | Alterations of wnt/beta-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis c virus. |
| PubMedID- 21319193 | Liver stiffness measurement (lsm) using fibroscan accurately assesses the degree of liver fibrosis and the risk of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |